Download Guidelines

Abstract Submission Opens

12:00 AM

Abstract Submission Closes

12:00 AM

Abstract Notifications

12:00 AM

Accepted Author Registration Deadline

12:00 AM

#TTLC25 in Huntington Beach

February 19 - February 22

Submission Categories

Antibody Drug Conjugates

Early-Stage Cancer

Immunotherapy
Small Cell Lung Cancer
Stage III Cancer
Targeted Therapies

Education Awards

Education Awards are available for Early Career Professionals, Trainees, and Residents. These awards will consist of complimentary registration to the Conference, up to three nights’ accommodation, a fixed amount to cover travel expenses, and free membership to the IASLC for one year.

Eligibility for Education Award

Applicants with a professional degree, must be a fellow, student, trainee or a post-doctoral researcher within three years of initial faculty appointment (for example, the candidate must be appointed to faculty no later than October 2021)
Postdoctoral researchers from non-profit institutions (including academic and governmental institutions) are eligible to apply
Submitter and presenter of an abstract accepted for presentation at TTLC 2025

Supporting Documents Required for Application

Letter outlining why attending the Conference would benefit your career (max. 400 words)

How to apply

The Education Award application is an integrated part of the abstract submission process. While completing your abstract, select the Education Award option.

Timeline

Application deadline: November 22, 2024
Notifications of acceptance: December 20, 2024

Contact

For any education awards related questions, please contact meetings@iaslc.org.

Notification & Communication Policy

The IASLC will communicate the acceptance status of the submitted abstract with the individual listed under 'Contact Information' on the Abstract Submission Portal. It is the responsibility of this individual to communicate with alternate presenters, authors or individuals on their team.

Publication Schedule

Abstract titles will be listed on the website program one month prior to the start of the conference.

Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation.

Confidentiality Policy

Authors who do not wish to have their abstracts published must notify the IASLC by email when submitting their final poster.

The authors of the abstract retain copyright, however IASLC reserves the right to sell and retain any revenue/income from selling the abstracts, presentation materials or recordings of the presentations.

Plagiarism Policy

Plagiarism encompasses all of the following:

Direct: intentionally submitting another person’s words or ideas verbatim as one’s own;

Self-plagiarism: submitting work that has been previously published or presented;

Mosaic plagiarism: stringing together portions of text from other sources;

Lack of attribution: failing to appropriately identify and cite sources for language or ideas that are incorporated.

For more information see: Das N, Panjabi M. Plagiarism: Why is it such a big issue for medical writers? Perspect Clin Res. 2011;2(2):67–71. doi:10.4103/2229-3485.80370 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121267/

Screening: IASLC screens all abstracts using anti-plagiarism software. Abstracts identified as having high levels of plagiarized content will be evaluated by IASLC staff and appropriate actions taken. Penalties for plagiarism may include: Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences.

For inquiries, please contact meetings@iaslc.org

No search results found